Brief: Aileron Therapeutics Presents New Clinical Data For ALRN-6924 at ESMO Virtual Congress 2021
16/09/2021 13:43
Sept 16 (Reuters) - Aileron Therapeutics Inc ALRN.O :
* AILERON THERAPEUTICS - PRESENTS NEW CLINICAL DATA AT ESMO
VIRTUAL CONGRESS 2021 SUPPORTING ALRN-6924'S BEST-IN-CLASS
POTENTIAL AS A CHEMOPROTECTIVE AGENT
Source text for Eikon: ID:nGNX6N1yXV
Further company coverage: ALRN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rein Therapeutics
See all newsBrief: Rein Therapeutics Receives U.S. FDA Fast Track Designation For Lti-03 In Idiopathic Pulmonary Fibrosis
Rein Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Rein Therapeutics Q2 net loss narrows on lower R&D spending
Rein Therapeutics Inc expected to post a loss of 17 cents a share - Earnings Preview
Brief: Rein Therapeutics Announces Closing Of $57.5 Million Underwritten Public Offering